PUBLICATION

Engineering & Mining Journal

AUTHORS

Alfonso Tejerina, Miguel Pérez-Solero, Lina Jafari, Lucrezia Falcidia

DOWNLOAD THE FULL PDF

Peru Mining 2019 E&MJ Release

Mining

Peru

August 19, 2019

Total mining investment in Peru amounted to US$4.95 billion in 2018, according to the Ministry of Energy and Mines (MEM). This represents close to a 26% increase from the US$3.93 billion invested in 2017. From the point of view of copper production there were no significant changes during 2018, although the expansions of Toquepala and Toromocho and the upcoming entry in production of Mina Justa and Quellaveco will be adding new capacity soon. The country, however, continues to face significant social opposition to certain mining projects: after an escalation of protests, the government recently decided to suspend the license for the construction of the US$1.4 billion Tía María copper project, which had been granted just a few weeks before.

RELATED INTERVIEWS MORE INTERVIEWS

Raphael Khalifa

FOUNDER, TEMBO POWER

Tembo Power is developing hydropower projects across Africa with a focus on DRC.

CEO, CHESSER RESOURCES

Chesser Resources is upbeat about its Diamba Sud gold resource in Eastern Senegal.

Robocon speaks with GBR about the outlook for its services in Peru.

"Our product innovation process involves gathering client feedback and submitting it to the factory, which determines which ideas to pursue based on economic considerations."

Mining

Chile

B.C. Mining Enters an Era of Reconciliation

British Columbia Mining 2019 Pre-Release Edition

True cohesion between government, Indigenous groups and the sector is the priority.

Mining

Peru

Canada

The Global Tailings Standard

The mining industry and investment community are collaborating to mitigate a perpetual risk, after a series of high-profile disasters.

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.

MORE PREVIOUSLY PUBLISHED